Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kazuhiko Takahashi, Hiroaki Suwa, Tomoo Ishikawa, Hidehito Kotani
Published in Volume 110, Issue 12
J Clin Invest. 2002; 110(12):1791 doi:10.1172/JCI15784
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2007 2006 2005 2004 2003 Total
Citations: 4 5 3 2 3 17

Citations to this article in CrossRef (17)

Title and authors Publication Year
Folia Pharmacologica Japonica
Shigeru Tokita
Folia Pharmacol. Jpn. 2007
Roles of central histaminergic system in glucose metabolisms and food intake in sheep
Yohei KUROSE, Yoshiaki TERASHIMA
Animal Sci J 2007
Histamine and the Regulation of Body Weight
Emilie A. Jørgensen, Ulrich Knigge, Jørgen Warberg, Andreas Kjær
Neuroendocrinology 2007
Adiposopathy: Treating pathogenic adipose tissue to reduce cardiovascular disease risk
Harold Bays, Helena W. Rodbard, Alan Bruce Schorr, J. Michael González-Campoy
Curr Treat Options Cardio Med 2007
Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo
D. R. Powell
Obesity Reviews 2006
Weight loss in overweight patients maintained on atypical antipsychotic agents
F Centorrino, J J Wurtman, K A Duca, V H Fellman, K V Fogarty, J M Berry, D M Guay, M Romeling, J Kidwell, S L Cincotta, R J Baldessarini
Int J Obes Relat Metab Disord 2006
Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.
Ryo Yoshimoto, Yasuhisa Miyamoto, Ken Shimamura, Akane Ishihara, Kazuhiko Takahashi, Hidehito Kotani, Airu S Chen, Howard Y Chen, Douglas J Macneil, Akio Kanatani, Shigeru Tokita
Proc. Natl. Acad. Sci. U.S.A. 2006
Recent Advances in Molecular Pharmacology of the Histamine Systems: Physiology and Pharmacology of Histamine H3 Receptor: Roles in Feeding Regulation and Therapeutic Potential for Metabolic Disorders
Shigeru Tokita, Kazuhiko Takahashi, Hidehito Kotani
J Pharmacol Sci 2006
Targeting of the central histaminergic system for treatment of obesity and associated metabolic disorders
Kjell Malmlöf, Rolf Hohlweg, Karin Rimvall
Drug Dev. Res. 2006
Assessment of pharmacology and potential anti-obesity properties of H3receptor antagonists/inverse agonists
Arthur A Hancock, Michael E Brune
Expert Opin. Investig. Drugs 2005